Hormonal drugs

Found 4
Gonadorelin (gonadorelin acetate) 20 ml
Composition: 1.0 ml of the preparation contains 0.0001 g of gonadorelin acetate, excipients and solvent up to 1 ml.
Application: intravenously
Indications: the drug is used to regulate reproductive function in cattle, dogs and rabbits.
Rutocin 100 ml
Composition: 1.0 ml of the drug contains 0.07 mg of cabertocin and solvent up to 1.0 ml.
Application: intravenously, intravenously
Indications: the drug is used in cows and sows with weak labor, retention of the placenta, subinvolution of the uterus, endometritis, mastitis, hypo- and agalactia, MMA syndrome in sows, to synchronize farrowing, to regulate milk flow in sows. Pharmachologic effect: Cabertocin has a prolonged effect, increases tone and enhances the contractile activity of the myometrium. It causes a reduction in the myoepithelium of the alveoli of the mammary gland, contributing to increased milk flow.
Surfagon-Rn 20 ml
Composition: 1.0 ml of the drug contains: surfagon - 5 μg, excipients and solvent - up to 1.0 ml.
Application: intravenously
Indications: for early induction of the sexual cycle; - for the treatment of hypofunction and follicular ovarian cysts; - to prevent early embryonic mortality; - to increase the fertility of cows and heifers; - induction of superovulation in donor cows; - stimulation and increase of sows fertility; - increasing the fertility of ewes; - stimulation of hunting and increasing the fertility of female rabbits with artificial insemination; The drug is administered intramuscularly
Estrofan-Rn 10 ml
Composition: 1.0 ml of the drug contains cloprostenol in the form of sodium salt - 250 μg, as well as auxiliary substances and solvent - up to 1.0 ml.
Application: intravenously
Indications: The drug is used to regulate reproductive function and treat its pathologies in females of farm animals, including: induction of sexual heat in cows, induction of farrowing in sows; treatment of cows with various forms of ovarian dysfunction: persistent corpus luteum, follicular (in combination with chorionic or luteinizing hormones) and luteal cysts, ovarian hypofunction (in combination with gonadotropin-releasing hormone, follicle-stimulating hormone or gonadotropin preparations), serum gonadotropin prophylaxis postpartum diseases of the uterus; termination of pregnancy with fetal pathologies.